Wagner S Brum, Nicholas J Ashton, Joel Simrén, Guiglielmo di Molfetta, Thomas K Karikari, Andrea L Benedet, Eduardo R Zimmer, Juan Lantero-Rodriguez, Laia Montoliu-Gaya, Andreas Jeromin, Aasne K Aarsand, William A Bartlett, Pilar Fernández Calle, Abdurrahman Coşkun, Jorge Díaz-Garzón, Niels Jonker, Henrik Zetterberg, Sverre Sandberg, Anna Carobene, Kaj Blennow
INTRODUCTION: Blood biomarkers have proven useful in Alzheimer's disease (AD) research. However, little is known about their biological variation (BV), which improves the interpretation of individual-level data. METHODS: We measured plasma amyloid beta (Aβ42, Aβ40), phosphorylated tau (p-tau181, p-tau217, p-tau231), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) in plasma samples collected weekly over 10 weeks from 20 participants aged 40 to 60 years from the European Biological Variation Study...
November 20, 2023: Alzheimer's & Dementia: the Journal of the Alzheimer's Association